Four patients had underlying non-malignant hematological conditions, two with aplastic anemia, one with beta-thalassemia following SCT, and one with neutropenia due to adenosine deaminase deficiency type 2 (ADA2) (Figure 1A). This evidence concerns the gene ADA2 and Decreased total neutrophil count.